Once-daily acebutolol and atenolol in essential hypertension: Double-blind crossover comparison

Abstract Acebutolol was compared to atenolol in 33 patients with mild to moderate essential hypertension (diastolic blood pressure > 95 mm Hg) with the use of a double-blind crossover study design. At 8 weeks of treatment, acebutolol, 400 mg once daily, and atenolol, 100 mg once daily, produced similar significant ( p p p